Turmeric is one the most completely examined plants today. Its therapeutic properties and segments (principally curcumin) have been the subject of more than 5600 peer-reviewed and published biomedical studies.
Actually, our five-year long research program on this divine plant has uncovered more than 600 potential preventive and remedial applications, and in addition 175 different useful physiological impacts. This whole database of 1,585 ncbi-hyperlinked turmeric abstracts can be downloaded as a PDF file at our page: Downloadable Turmeric Document.
Given the deep examination performed on this astounding spice, it is no big surprise that a developing number of studies have reasoned that it contrasts positively with a mixture of traditional medicines, such as:
LIPITOR/Atorvastatin (cholesterol MEDICATION)
A 2008 research published in the Drugs in R & D journal revealed that an institutionalized planning of curcuminoids from Turmeric contrasted positively with the medication atorvastatin dysfunction, the underlying pathology of the veins that drives atherosclerosis, connecting to decreases in irritation and oxidative stress, in type 2 diabetic patients.
CORTICOSTEROIDS (STEROID MEDICATIONS)
A 1999 research, published in the Phytotherapy Research journal, revealed that the essential polyphenol in turmeric, the saffron colored pigment known as curcumin, contrasted positively with steroids in the administration of chronic anterior uveitis, an incendiary eye sickness.
A 2008 research published in Critical Care Medicine revealed that curcumin contrasted positively with the corticosteroid drug dexamethasone in the animal model as an optional treatment for ensuring lung transplantation-related injury by down-directing incendiary genes.
A preceding 2003 research published in Cancer Letters discovered the same medication contrasted positively with dexamethasone in a lung ischaemia-repurfusion injury model, too.
PROZAC/FLUOXETINE & IMIPRAMINE (ANTIDEPRESSANTS)
A 2011 research published in the Acta Poloniae Pharmaceutica journal revealed that curcumin contrasted positively with both medications in decreasing depressive conduct in an animal model.
Aspirin (BLOOD THINNER)
A 1986 in vitro and ex vivo research published in the Arzneimittelforschung journal revealed that curcumin has anti-platelet and prostacyclin balancing impacts contrasted with aspirin, showing it may be beneficial to patients inclined to vascular thrombosis, and in need of anti-arthritis therapy.
ANTI-INFLAMMATORY DRUGS
A 2004 research published in the Oncogene journal revealed that curcumin (and resveratrol) were viable options to the medications aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in pushing calming and anti-proliferative actions against tumor cells.
OXALIPLATIN (CHEMOTHERAPY DRUG)
A 2007 research published in the International Journal of Cancer revealed that curcumin contrasts positively and oxaliplatin, as an antiproliferative agenet in colorectal cell lines.
METFORMIN (DIABETES DRUG)
A 2009 research published in the Biochemistry and Biophysical Research Community journal investigated how curcumin may be beneficial in treating diabetes, observing that it initiates AMPK (which expands glucose uptake) and suppresses gluconeogenic gene expression (which suppresses formulation of glucose in the liver) in hepatoma cells.
Fascinatingly, they discovered curcumin to be 500 times to 100,000 times (in the structure known as tetrahydrocurcuminoids(thc)) stronger than metformin in triggering AMPK and its downstream target acetyl-Coa carboxylase (ACC).
An alternative way in which turmeric and its segments uncover their noteworthy curative properties is in exploration of drug resistant- and multi-drug resistant tumors.
We have two categories on our site devoted to exploring natural and integrative treatments on these subjects, keeping in mind there are many substances with evident viability against these chemotherapy- and radiation-safe tumors, curcumin tops both records:
Tumors: Drug Resistant
Tumors: Multi-Drug Resistant
We have discovered more than 54 researches demonstrating that curcumin can incite cell death ensitize drug-resistant tumor cell lines to ordinary treatment.
We have distinguished 27 studies on curcumin’s capability to either cause cell death or sensitize multi-drug resistant tumor cells to ordinary treatment.
Considering the turmeric’s solid track record, used as both food and medicine in different cultures, for a huge number of years, a solid argument can be made for using curcumin as a medication or adjuvant in tumor treatment.
On the other hand, believe it or not, you can use confirmed natural (non-irradiated) turmeric in lower culinary measurements regularly, with the goal that courageous dosages won’t be fundamental later on, after the arrival of a serious illness. Feeding yourself, as opposed to curing yourself with “nutraceuticals,” ought to be the objective of a healthy eating regimen.
